THE WHAT? Henkel has closed the acquisition of a patented skin model technology from SkinInVitro. The epiCS® skin models will be manufactured in the Henkel laboratories in Dusseldorf under the German cosmetics manufacturer’s Phenion brand.
THE DETAILS The skin model technology comprises reconstructed human epidermal equivalents, which are officially approved by the OECD for assessing skin irritation, enabling safety assessments of end products and cosmetics ingredients without recourse to animal testing.
THE WHY? “With this acquisition we are strengthening our existing product portfolio in the field of reconstructed human tissue models,” explains Dirk Petersohn, responsible for the Phenion® brand at Henkel Beauty Care. “With the epiCS® technology we can now offer our clients tissue models which are well-suited and regulatory accepted for analyzing the skin-corrosive and irritating potential of substances. Hence, this reasonable complement of our already existing product portfolio gives us the opportunity to serve our customers even better. We are looking forward to integrating the SkinInVitro team in order to expedite together the development and distribution of alternative test methods.”